These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 21638520)
1. Safety surveillance of longitudinal databases: methodological considerations. Norén GN; Hopstadius J; Bate A; Edwards IR Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):714-7. PubMed ID: 21638520 [No Abstract] [Full Text] [Related]
2. Safety surveillance of longitudinal databases: further methodological considerations. Schuemie MJ Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):670-2; author reply 673-5. PubMed ID: 22678687 [No Abstract] [Full Text] [Related]
3. What Is the Plural of a 'Yellow' Anecdote? Evans SJ Drug Saf; 2016 Jan; 39(1):1-3. PubMed ID: 26597283 [No Abstract] [Full Text] [Related]
4. Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs. Lin KJ; Schneeweiss S Clin Pharmacol Ther; 2016 Aug; 100(2):147-59. PubMed ID: 26916672 [TBL] [Abstract][Full Text] [Related]
5. The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study. de Bie S; Coloma PM; Ferrajolo C; Verhamme KM; Trifirò G; Schuemie MJ; Straus SM; Gini R; Herings R; Mazzaglia G; Picelli G; Ghirardi A; Pedersen L; Stricker BH; van der Lei J; Sturkenboom MC; Br J Clin Pharmacol; 2015 Aug; 80(2):304-14. PubMed ID: 25683723 [TBL] [Abstract][Full Text] [Related]
6. Drug safety: withdrawn medications are only part of the picture. Rawson NS BMC Med; 2016 Feb; 14():28. PubMed ID: 26873482 [TBL] [Abstract][Full Text] [Related]
7. Methods for safety signal detection in healthcare databases: a literature review. Arnaud M; Bégaud B; Thurin N; Moore N; Pariente A; Salvo F Expert Opin Drug Saf; 2017 Jun; 16(6):721-732. PubMed ID: 28490262 [TBL] [Abstract][Full Text] [Related]
8. Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD. Schuemie MJ Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):292-9. PubMed ID: 20945505 [TBL] [Abstract][Full Text] [Related]
9. Detection of adverse drug reactions using hospital databases-a nationwide study in Portugal. Miguel A; Bernardo Marques ; Freitas A; Lopes F; Azevedo L; Pereira AC Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):907-13. PubMed ID: 23761351 [TBL] [Abstract][Full Text] [Related]
10. The 'power' of signal-detection algorithms. Karim MR; Klincewicz SL; Yee CL Drug Saf; 2008; 31(3):271-2, author reply 272-3. PubMed ID: 18302451 [No Abstract] [Full Text] [Related]
11. Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use. Li AS; Pomeranz HD J Neuroophthalmol; 2016 Dec; 36(4):480-481. PubMed ID: 27851718 [No Abstract] [Full Text] [Related]
12. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. Onakpoya IJ; Heneghan CJ; Aronson JK BMC Med; 2016 Feb; 14():10. PubMed ID: 26843061 [TBL] [Abstract][Full Text] [Related]
13. Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases. Maignen F; Hauben M; Hung E; Van Holle L; Dogne JM Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):195-207. PubMed ID: 24243665 [TBL] [Abstract][Full Text] [Related]
14. Exploration of statistical shrinkage parameters of disproportionality methods in spontaneous reporting system of China. Wang J; Ye XF; Guo XJ; Zhu TT; Qi N; Hou YF; Zhang TY; Shi WT; Wei X; Liu YZ; Wu GZ; He J Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):962-70. PubMed ID: 26095121 [TBL] [Abstract][Full Text] [Related]
15. Assessing performance of sequential analysis methods for active drug safety surveillance using observational data. Zhou X; Bao W; Gaffney M; Shen R; Young S; Bate A J Biopharm Stat; 2018; 28(4):668-681. PubMed ID: 29157113 [TBL] [Abstract][Full Text] [Related]
16. Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databases. Avillach P; Salvo F; Thiessard F; Miremont-Salamé G; Fourrier-Reglat A; Haramburu F; Bégaud B; Moore N; Pariente A; Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):186-94. PubMed ID: 23670805 [TBL] [Abstract][Full Text] [Related]
17. Automatic detection of adverse events to predict drug label changes using text and data mining techniques. Gurulingappa H; Toldo L; Rajput AM; Kors JA; Taweel A; Tayrouz Y Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1189-94. PubMed ID: 23935003 [TBL] [Abstract][Full Text] [Related]
18. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database. Roberto G; Piccinni C; D'Alessandro R; Poluzzi E Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799 [TBL] [Abstract][Full Text] [Related]
19. The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project. Raschi E; Poluzzi E; Salvo F; Koci A; Suling M; Antoniazzi S; Perina L; Hazell L; Moretti U; Sturkenboom M; Garbe E; Pariente A; De Ponti F Drug Saf; 2016 Jan; 39(1):59-68. PubMed ID: 26446144 [TBL] [Abstract][Full Text] [Related]